2026年是"十五五"规划开局之年，做好经济工作至关重要。图是高科技企业云集的深圳湾。 新华社发 12月8日，中共中央政治局召开会议，分析研究2026年经济工作。会议总结分析今年经济工作，对明年 经济工作作出一系列重要部署。 围绕做好明年经济工作，会议指出，"要坚持稳中求进、提质增效"，并提出做好明年经济工作的"八个 坚持"，将"坚持内需主导"置于首位。 2026年，中国经济如何前行?哪些重点领域值得关注? 八家券商先后发表观点对此作出深入解读。 政策基调 "要坚持稳中求进、提质增效" 2026年是"十五五"规划开局之年，做好经济工作至关重要。"十五五"规划建议指出，"'十五五'时期我国 发展环境面临深刻复杂变化"，"我国发展处于战略机遇和风险挑战并存、不确定难预料因素增多的时 期"。围绕做好明年经济工作，会议指出，"要坚持稳中求进、提质增效"。 华泰证券认为，从"以进促稳"到"提质增效"，经济政策基调从"进"和"立"到重"质"和"效"。从政策基调 的措辞看，今年政治局会议要求"稳中求进、提质增效"，而2024年12月政治局会议则强调"坚持稳中求 进、以进促稳，守正创新、先立后破，系统集成、协同配合"，主因去 ...

Core Insights - The 2025 Wind "Gold Analyst" awards were announced on December 10, recognizing outstanding research teams based on the number of report reads from buy-side institutions [1]. Group 1: Award Winners - The awards included 33 individual research field awards and 4 institutional awards, with participation from over 600 teams from 38 research institutions [1]. - Notable winners in various categories include: - Strategy Research: - First: Galaxy Securities - Second: Guosen Securities - Third: Zheshang Securities [3] - Fixed Income: - First: Zheshang Securities - Second: Huachuang Securities - Third: Dongwu Securities [3] - ESG Research: - First: Guosen Securities - Second: Galaxy Securities - Third: Zheshang Securities [5] - Restaurant and Tourism: - First: Guosen Securities - Second: Kaiyuan Securities - Third: Dantan Haidao [6] - Media: - First: Dongwu Securities - Second: Guohai Securities - Third: Kaiyuan Securities [7] Group 2: Sector-Specific Insights - In the Electric Power and Utilities sector: - First: Dongwu Securities - Second: Guosen Securities - Third: Tianfeng Securities [8] - In the Real Estate sector: - First: Kaiyuan Securities - Second: Everbright Securities - Third: Zhongxin Jian Investment [11] - In the Automotive sector: - First: Dongwu Securities - Second: Minsheng Securities - Third: Guosen Securities [31] - In the Non-Bank Financial sector: - First: Zhongxin Jian Investment - Second: Kaiyuan Securities - Third: Dongwu Securities [21] Group 3: Overall Trends - The awards reflect a competitive landscape among research institutions, with a significant number of teams participating and a diverse range of sectors represented [1][3]. - The methodology for the awards was based on objective metrics, specifically the reading counts of research reports by buy-side institutions, ensuring a transparent evaluation process [1].

Core Viewpoint - The continuous decline in the number of shareholders for certain companies indicates a trend of increasing concentration of shares, with 122 companies experiencing a decrease for more than three consecutive periods, and some seeing declines for up to 13 periods [1] Group 1: Shareholder Trends - A total of 985 companies reported their latest shareholder numbers as of November 30, with 122 companies showing a continuous decline in shareholder numbers [1] - Notable companies with significant declines include ST Renzihang, which has seen a 23.81% drop in shareholder numbers over 13 periods, and Rundu Co., which has experienced a 40.50% decline over 11 periods [1] - Other companies with notable declines include Yihua New Materials and ST Huike, among others [1] Group 2: Market Performance - Among the companies with declining shareholder numbers, 36 have seen their stock prices rise, while 86 have experienced declines, with notable gainers including Shibu Testing (up 73.16%), Anlian Ruishi (up 58.15%), and Xianhe Environmental (up 32.00%) [2] - 37 companies, representing 30.33%, outperformed the Shanghai Composite Index during this period, with Shibu Testing, Anlian Ruishi, and Fuzheng Technology showing relative returns of 74.30%, 55.80%, and 32.87%, respectively [2] Group 3: Industry and Institutional Insights - The industries with the highest concentration of companies experiencing declining shareholder numbers include machinery, pharmaceuticals, and construction, with 18, 9, and 9 companies respectively [2] - In terms of market segments, 73 companies are listed on the main board, 47 on the ChiNext board, and 2 on the Sci-Tech Innovation board [2] - In the past month, 17 companies with declining shareholder numbers have been subject to institutional research, with Yunnan Copper, Great Wall Securities, and China Electric Port receiving the most attention [2]

12月8日，中共中央政治局召开会议，分析研究2026年经济工作。会议总结分析今年经济工作，对明年 经济工作作出一系列重要部署。 围绕做好明年经济工作，会议指出，"要坚持稳中求进、提质增效"，并提出做好明年经济工作的"八个 坚持"，将"坚持内需主导"置于首位。 2026年，中国经济如何前行？哪些重点领域值得关注？ 八家券商先后发表观点对此作出深入解读。 政策基调："提质增效" 2026年是"十五五"规划开局之年，做好经济工作至关重要。"十五五"规划建议指出，"'十五五'时期我国 发展环境面临深刻复杂变化"，"我国发展处于战略机遇和风险挑战并存、不确定难预料因素增多的时 期"。围绕做好明年经济工作，会议指出，"要坚持稳中求进、提质增效"。 明年初财政前置发力形成一定支撑。同时5000亿元新型政策性金融工具已全部投放，但对贷款的带动作 用仍有限，或亦将在明年开门红中集中开始体现。 华泰证券认为，从"以进促稳"到"提质增效"，经济政策基调从"进"和"立"到重"质"和"效"。 从政策基调的措辞看，今年政治局会议要求"稳中求进、提质增效"，而2024年12月政治局会议则强 调"坚持稳中求进、以进促稳，守正创新、先立后破， ...

Group 1 - The core viewpoint of the article is that Amway Co., Ltd. (SZ 300218) announced an investor research meeting scheduled for December 8, 2025, where company executives will address investor inquiries [1] - For the year 2024, Amway's revenue composition is reported to be 98.35% from synthetic leather and 1.65% from other businesses [1] - As of the report, Amway's market capitalization stands at 3.5 billion yuan [1]

Core Viewpoint - Hainan Baimaike Medical Technology Co., Ltd. has officially received acceptance for its initial public offering (IPO) application, aiming to raise approximately 306 million RMB for its advanced medical device project, marking a significant step into the capital market for the company focused on surgical sutures and medical consumables [1][2]. Company Overview - Baimaike specializes in surgical sutures, interventional embolization materials, and hemostatic materials, with a presence in around 3,000 hospitals across China, covering all 31 provinces and regions [8]. - The company has a dual focus on consumables and medical equipment, including peptide synthesis and cleavage devices, which helps diversify its product offerings and mitigate risks associated with reliance on a single product line [14]. IPO Process - The IPO process for Baimaike has been notably swift, taking approximately six months from the completion of listing guidance in June 2025 to the acceptance announcement in December 2025 [2][6]. - The funds raised from the IPO will be allocated to expanding production, upgrading equipment automation, and establishing a materials and process research center [6][7]. Market Opportunity - The domestic surgical suture market, historically dominated by foreign brands, is experiencing a shift towards domestic alternatives due to increased demand for cost control and supply chain security in hospitals [3]. - The market for surgical sutures in China is projected to grow at a compound annual growth rate (CAGR) of nearly 9% in the coming years, driven by advancements in minimally invasive surgery and the introduction of new materials and technologies [3]. Financial Performance - Baimaike's revenue has shown significant growth, increasing from approximately 90.67 million RMB in 2022 to 185 million RMB in 2024, with net profit rising from about 29.5 million RMB to approximately 69.19 million RMB during the same period [9]. - As of mid-2025, the company reported a revenue of around 95.81 million RMB and a net profit of approximately 35 million RMB, maintaining a gross margin above 75% [9]. Product Strengths - The company's core products include absorbable surgical sutures, barbed sutures, and functional coated sutures, designed to meet the needs of various surgical departments [11]. - Baimaike's absorbable sutures are made from poly-ε-caprolactone, offering features such as knotless functionality and complete degradation within 180-220 days, which aligns with the high safety and cost-effectiveness demands of domestic hospitals [14]. Conclusion - Baimaike's journey from research to production and now to the capital market reflects the broader transition of domestic medical device companies from followers to builders in the industry [15]. - The successful fundraising and planned capacity expansion could position Baimaike as a significant player in the high-frequency surgical consumables and basic medical device sectors in China, potentially serving as a model for other domestic medical device companies [15].

Group 1 - The A-share market showed overall strength on December 8, with AI hardware stocks such as optical modules and high-speed copper connections becoming active, particularly in the ChiNext market where AI stocks surged [1] - Tianfu Communication rose over 13%, Zhishang Technology increased by more than 8%, and Zhongji Xuchuang gained over 4% [1] - The largest and most liquid AI-themed ETF in the ChiNext market (159363) rose over 4.8% after opening, reaching a new historical high with real-time transaction volume exceeding 300 million yuan, ranking first among AI-themed ETFs in the entire market [1] Group 2 - Changcheng Securities believes that the continuous implementation of AI applications will accelerate the construction of computing power infrastructure, both foundational and edge computing power, leading to investment opportunities in the related industry chain [1] - The report highlights the AIDC industry chain, including optical modules, PCBs, main equipment manufacturers, and copper cables, as essential supports for computing power, with rapidly released demand and a potential double boost in performance and valuation for the industry chain [1] - The report suggests focusing on the first AI-themed ETF in the ChiNext market (159363) and its off-market connection (023407), with a key index focusing on the optical module leader "Yizhongtian," which has over 56% optical module content [1] - Over 70% of the portfolio is allocated to computing power, while more than 20% is allocated to AI applications, effectively capturing the AI thematic market [1]

Core Viewpoint - The performance of brokerage firms has significantly improved in 2023, with a 62.48% year-on-year increase in net profit for 43 A-share listed brokerages in the first three quarters, leading to heightened interest from financial institutions in conducting research on these firms [1][6]. Group 1: Internationalization Efforts - Chinese brokerages are accelerating their internationalization efforts, viewing overseas markets as essential for performance growth. Notable actions include Guotai Junan's acquisition of an Indonesian securities company and Dongxing Securities' HK$300 million capital increase for its Hong Kong subsidiary [2][7]. - Leading brokerages like China Merchants Securities are adopting a dual strategy focusing on both the Hong Kong market and broader international markets, enhancing their digital operations and cross-border investment channels [2][7]. - Smaller brokerages are also pursuing internationalization, with Northeast Securities planning to establish a Hong Kong subsidiary and Changcheng Securities already in the process of obtaining a business license for its new Hong Kong entity [3][8]. Group 2: Investment Banking Recovery - The investment banking sector has seen a notable recovery, with net income from underwriting fees for listed brokerages increasing by 23.46% year-on-year in the first three quarters [4][9]. - Brokerages are focusing on differentiated development paths, with Northeast Securities targeting small and innovative enterprises, while First Capital is expanding its business in the Beijing-Tianjin-Hebei region [4][9]. - Analysts predict that future growth in investment banking will be driven by opportunities in technology innovation and new production capabilities, with an emphasis on enhancing service capabilities for tech enterprises [5][10].

Core Viewpoint - The performance of A-share listed securities firms has significantly improved in 2023, with a net profit growth of 62.48% year-on-year in the first three quarters, leading to increased interest from financial institutions in conducting research on these firms [1] Group 1: Internationalization Efforts - Chinese securities firms are accelerating their internationalization efforts, viewing overseas markets as essential for performance growth. For instance, Guotai Junan announced plans to acquire an Indonesian securities company, while Dongxing Securities increased its investment in its Hong Kong subsidiary by 300 million HKD [2] - Leading firms like China Merchants Securities are adopting a dual strategy focusing on both the Hong Kong market and broader international markets, enhancing their global trading platform and digital operations [2] - Smaller firms are also pursuing internationalization, with Northeast Securities preparing to establish a subsidiary in Hong Kong and Changcheng Securities applying for a business license for its new Hong Kong subsidiary [3] Group 2: Investment Banking Recovery - The investment banking sector has seen a notable recovery, with net income from underwriting fees for listed securities firms increasing by 23.46% year-on-year in the first three quarters [4] - Firms are focusing on differentiated development paths, with Northeast Securities targeting small and innovative enterprises, while First Capital is expanding its business in the Beijing-Tianjin-Hebei region [4] - Analysts predict that the investment banking business will continue to recover, with opportunities in equity financing concentrated in technology innovation and new production capabilities, alongside a growing trend in debt financing [5]

Investment Rating - The report maintains an "Overweight" rating for the securities industry [2][7][26] Core Views - The securities sector is experiencing a recovery in performance expectations, with the price-to-book (PB) ratio having fallen to a low level not seen in the past decade, indicating high allocation value and safety margins [7][26] - The average daily trading volume in the stock market has been declining for three consecutive weeks, with a current average of 16,843 billion yuan, reflecting a 2.4% decrease week-on-week [5][13] - The report highlights that the financing scale for equity financing has increased significantly year-to-date, with a 259% year-on-year growth, indicating robust market activity [17][21] Summary by Sections Market Review - The Shanghai Composite Index rose by 0.4%, while the CSI 300 Index increased by 1.3% during the week of December 1-5, 2025 [4][9] - The non-bank financial index increased by 2.3%, outperforming the CSI 300 by 1 percentage point [4][9] - The broker index rose by 1.1%, slightly underperforming the CSI 300 [4][9] Brokerage Business - The average daily stock trading volume for the two markets was 16,843 billion yuan, down 2.4% week-on-week [5][13] - In November, the average daily trading volume was 18,978 billion yuan, showing a year-on-year decrease of 1.67% and a month-on-month decrease of 11.5% [5][13] Investment Banking Business - Four companies conducted equity financing during the week, raising a total of 12.8 billion yuan, a 19% decrease from the previous week [17][21] - Year-to-date, the total equity financing scale has increased by 259%, with IPO financing up by 94% [17][21] Capital Intermediation Business - As of December 5, the margin financing and securities lending balance reached 24,839 billion yuan, a 0.4% increase week-on-week [6][21] - The financing balance increased to 24,665 billion yuan, maintaining a high level for the year [6][21]